Physicians' Academy
for Cardiovascular Education
Agenda
Topics
▼
Media
▼
Online-CME
News
▼
Meeting Reports
Slides
▼
About
ACC 2020
▼
AHA 2020
▼
Covid-19
▼
Diabetes & CVD
▼
ESC 2020
▼
HF Practical Tutorials
▼
Kidney disease & CVD
▼
HoFH: Prevalence and new treatments
3' education - Sep. 1, 2013 - Snapshot 2013 - Dr Kees Hovingh
Dr. Kees Hovingh, AMC, Amsterdam, reviews recent data on the prevalence, phenotype and novel treatment options for patients with Homozygous Familial Hypercholesterolaemia.
Share this page with your colleagues and friends:
Share this page with your colleagues and friends: